STUDY OF ANTI-MULLERIAN HORMONE LEVELS IN A SAMPLE OF POLYCYSTIC OVARY SYNDROME WOMEN ACROSS AGE GROUPS

Document Type : Preliminary preprint short reports of original research

Authors

1 Department of Obstetrics and Gynecology, Faculty of Medicine, University of Alexandria.

2 Department of Obstetrics and Gynecology Faculty of Medicine Alexandria University

3 Department of Obstetrics & Gynecology, Faculty of Medicine, Alexandria University.

Abstract

INTRODUCTION:
Anti-Mullerian hormone (AMH) appears to be the most promising predictor of ovarian reserve in non-PCOS women, regardless of chronological age, of all the hormonal and sonographic approaches tested. Women with PCOS have somewhat similar evidence. PCOS-affected women exhibit higher AMH concentrations than non-PCOS women, suggesting that AMH concentration may be a sign of extended fertility in these women.

AIM OF THE WORK:
The aim of this study was to predict the age of AMH decline in PCO women.

PATIENTS AND METHODS:
This was a clinical trial study was carried out on 90 PCO patients in obstetrics and Gynecology department at Elshatby university hospital.

RESULTS:
The level of AMH show a highly significant difference between the five studied groups, AMH in group I ranged from 4.65-6.5 with mean value 5.60±0.62, in group II ranged from 3.55-5 with mean value 4.15±0.47, in group III ranged from 2.08-3.5 with mean value 2.76±0.46, in group IV ranged from 1.26-3 with mean value 1.94±0.58 and in group V ranged from 0.75-2.43 with mean value 1.26±0.54. There was statistical significant increase in groups I and II than groups III, IV.

Keywords

ALEXMED ePosters
Volume 7, Issue 1
January 2025
Pages 41-42

Files

Share

How to cite

Statistics